Dragan Grabulovski

Dragan Grabulovski is currently serving as the Acting CEO, Co-founder, and Chairman at Araris Biotech AG in Zurich, where he leads strategic planning, drug discovery, and management in the biotechnology and pharmaceutical industry. With a Ph.D. from ETH Zürich, Dragan has held key roles at various companies, including being a Venture Partner at Pureos Bioventures and serving as CSO and co-founder at Covagen, now part of the Janssen Pharmaceutical Companies of Johnson & Johnson.